Publications by authors named "Peter Bettelheim"

Claim this Profile
I
Implementation of a one-tube flow cytometry panel for measurable residual disease detection in multiple myeloma patients in clinical routine.
Karin Deutsch-Biedermann, Katrin Hefler-Frischmuth, Judith Gruber, Christine Kimbacher, Isabella Herbring, Peter Bettelheim

Cytometry B Clin Cytom· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRD4 degraders may effectively counteract therapeutic resistance of leukemic stem cells in AML and ALL.
Karin Bauer, Alexander Hauswirth, Karoline V Gleixner, Georg Greiner, Johannes Thaler, Peter Bettelheim

Am J Hematol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CAR virus receptor mediates erythroid differentiation and migration and is downregulated in MDS.
Karin Bauer, Sigrid Machherndl-Spandl, Lukas Kazianka, Irina Sadovnik, Sinan Gültekin, Peter Bettelheim

Leukemia· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic characterization of disease-initiating stem cells in JAK2- or CALR-mutated myeloproliferative neoplasms.
Daniel Ivanov, Jelena D Milosevic Feenstra, Irina Sadovnik, Harald Herrmann, Barbara Peter, Peter Bettelheim

Am J Hematol· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet.
Vincent H J van der Velden, Frank Preijers, Ulrika Johansson, Theresia M Westers, Alan Dunlop, Peter Bettelheim

Cytometry B Clin Cytom· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical application of flow cytometry in patients with unexplained cytopenia and suspected myelodysplastic syndrome: A report of the European LeukemiaNet International MDS-Flow Cytometry Working Group.
Arjan A van de Loosdrecht, Wolfgang Kern, Anna Porwit, Peter Valent, Sharham Kordasti, Peter Bettelheim

Cytometry B Clin Cytom· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
ELN iMDS flow working group validation of the monocyte assay for chronic myelomonocytic leukemia diagnosis by flow cytometry.
Orianne Wagner-Ballon, Peter Bettelheim, Jeroen Lauf, Frauke Bellos, Matteo Della Porta

Cytometry B Clin Cytom· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicenter prospective evaluation of diagnostic potential of flow cytometric aberrancies in myelodysplastic syndromes by the ELN iMDS flow working group.
Wolfgang Kern, Theresia M Westers, Frauke Bellos, Marie Christine Bene, Peter Bettelheim

Cytometry B Clin Cytom· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issues: Recommendations from the European LeukemiaNet/International Myelodysplastic Syndrome Flow Cytometry Working Group.
Anna Porwit, Marie C Béné, Carolien Duetz, Sergio Matarraz, Uta Oelschlaegel, Peter Bettelheim

Cytometry B Clin Cytom· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms.
Jelena D Milosevic Feenstra, Roland Jäger, Fiorella Schischlik, Daniel Ivanov, Gregor Eisenwort, Peter Bettelheim

Am J Hematol· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Secondary basophilic leukemia in Ph-negative myeloid neoplasms: A distinct subset with poor prognosis.
Daniela Berger, Karin Bauer, Christoph Kornauth, Susanne Gamperl, Gabriele Stefanzl, Peter Bettelheim

Neoplasia· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phenotypic characterization of leukemia-initiating stem cells in chronic myelomonocytic leukemia.
Gregor Eisenwort, Irina Sadovnik, Alexandra Keller, Daniel Ivanov, Barbara Peter, Peter Bettelheim

Leukemia· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of age on the cumulative risk of transformation in patients with chronic myelomonocytic leukaemia.
Sigrid Machherndl-Spandl, Eva Jäger, Agnes Barna, Michael Gurbisz, Renate Marschon, Peter Bettelheim

Eur J Haematol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical, Hematologic, Biologic and Molecular Characteristics of Patients with Myeloproliferative Neoplasms and a Chronic Myelomonocytic Leukemia-Like Phenotype.
Sonja Heibl, Bettina Gisslinger, Eva Jäger, Agnes Barna, Michael Gurbisz, Peter Bettelheim

Cancers (Basel)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correlation of RAS-Pathway Mutations and Spontaneous Myeloid Colony Growth with Progression and Transformation in Chronic Myelomonocytic Leukemia-A Retrospective Analysis in 337 Patients.
Klaus Geissler, Eva Jäger, Agnes Barna, Michael Gurbisz, Temeida Graf, Peter Bettelheim

Int J Mol Sci· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Austrian biodatabase for chronic myelomonocytic leukemia (ABCMML) : A representative and useful real-life data source for further biomedical research.
Klaus Geissler, Eva Jäger, Agnes Barna, Michael Gurbisz, Renate Marschon, Peter Bettelheim

Wien Klin Wochenschr· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD13 expression in B cell malignancies is a hallmark of plasmacytic differentiation.
Anna Raimbault, Sigrid Machherndl-Spandl, Raphaël Itzykson, Sylvain Clauser, Nicolas Chapuis, Peter Bettelheim

Br J Haematol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Normal and pathological erythropoiesis in adults: from gene regulation to targeted treatment concepts.
Peter Valent, Guntram Büsche, Igor Theurl, Iris Z Uras, Ulrich Germing, Peter Bettelheim

Haematologica· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The KIT and PDGFRA switch-control inhibitor DCC-2618 blocks growth and survival of multiple neoplastic cell types in advanced mastocytosis.
Mathias Schneeweiss, Barbara Peter, Siham Bibi, Gregor Eisenwort, Dubravka Smiljkovic, Peter Bettelheim

Haematologica· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis, management and response criteria of iron overload in myelodysplastic syndromes (MDS): updated recommendations of the Austrian MDS platform.
Peter Valent, Reinhard Stauder, Igor Theurl, Klaus Geissler, Thamer Sliwa, Peter Bettelheim

Expert Rev Hematol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pan-BCL-2-blocker obatoclax (GX15-070) and the PI3-kinase/mTOR-inhibitor BEZ235 produce cooperative growth-inhibitory effects in ALL cells.
Gabriele Stefanzl, Daniela Berger, Sabine Cerny-Reiterer, Katharina Blatt, Gregor Eisenwort, Peter Bettelheim

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proposed minimal diagnostic criteria for myelodysplastic syndromes (MDS) and potential pre-MDS conditions.
Peter Valent, Attilio Orazi, David P Steensma, Benjamin L Ebert, Detlef Haase, Peter Bettelheim

Oncotarget· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunophenotypic analysis of erythroid dysplasia in myelodysplastic syndromes. A report from the IMDSFlow working group.
Theresia M Westers, Eline M P Cremers, Uta Oelschlaegel, Ulrika Johansson, Peter Bettelheim

Haematologica· February 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic mast cell leukemia (MCL) with KIT S476I: a rare entity defined by leukemic expansion of mature mast cells and absence of organ damage.
Peter Valent, Jörg Berger, Sabine Cerny-Reiterer, Barbara Peter, Gregor Eisenwort, Peter Bettelheim

Ann Hematol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
10th anniversary of the Austrian MDS Platform: aims and ongoing projects.
Sonja Burgstaller, Peter Bettelheim, Otto Krieger, Sigrid Machherndl-Spandl, Thomas Nösslinger

Wien Klin Wochenschr· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis